BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang C, Gao Y, Fan Y, Cao L, Li J, Ge Y, Tu W, Liu Y, Cao X, Shi X. Dual-mode endogenous and exogenous sensitization of tumor radiotherapy through antifouling dendrimer-entrapped gold nanoparticles. Theranostics 2021;11:1721-31. [PMID: 33408777 DOI: 10.7150/thno.54930] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming Nuclear Medicine with Nanoradiopharmaceuticals. ACS Nano 2022. [PMID: 35294165 DOI: 10.1021/acsnano.1c10550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ouyang Z, Gao Y, Yang R, Shen M, Shi X. Genetic Engineering of Dendritic Cells Using Partially Zwitterionic Dendrimer-Entrapped Gold Nanoparticles Boosts Efficient Tumor Immunotherapy. Biomacromolecules 2022. [PMID: 35235306 DOI: 10.1021/acs.biomac.1c01571] [Reference Citation Analysis]
3 Chen J, Dong H, Bai L, Li L, Chen S, Tian X, Pan Y. Multifunctional high-Z nanoradiosensitizers for multimodal synergistic cancer therapy. J Mater Chem B 2022;10:1328-42. [PMID: 35018941 DOI: 10.1039/d1tb02524d] [Reference Citation Analysis]
4 Qian H, Wang K, Lv M, Zhao C, Wang H, Wen S, Huang D, Chen W, Zhong Y. Recent advances on next generation of polyzwitterion-based nano-vectors for targeted drug delivery. J Control Release 2022:S0168-3659(22)00079-7. [PMID: 35149143 DOI: 10.1016/j.jconrel.2022.02.004] [Reference Citation Analysis]
5 Zhang X, He C, Xiang G. Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy. Cancer Lett 2022:S0304-3835(22)00020-9. [PMID: 35041892 DOI: 10.1016/j.canlet.2022.01.012] [Reference Citation Analysis]
6 Sun Y, Zhou Z, Yang S, Yang H. Modulating hypoxia inducible factor-1 by nanomaterials for effective cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1766. [PMID: 34713633 DOI: 10.1002/wnan.1766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gao Y, Ouyang Z, Yang C, Song C, Jiang C, Song S, Shen M, Shi X. Overcoming T Cell Exhaustion via Immune Checkpoint Modulation with a Dendrimer-Based Hybrid Nanocomplex. Adv Healthc Mater 2021;10:e2100833. [PMID: 34212538 DOI: 10.1002/adhm.202100833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Wang D, Chen L, Gao Y, Song C, Ouyang Z, Li C, Mignani S, Majoral JP, Shi X, Shen M. Impact of molecular rigidity on the gene delivery efficiency of core-shell tecto dendrimers. J Mater Chem B 2021;9:6149-54. [PMID: 34328166 DOI: 10.1039/d1tb01328a] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
10 Ouyang Z, Gao Y, Shen M, Shi X. Dendrimer-based nanohybrids in cancer photomedicine. Mater Today Bio 2021;10:100111. [PMID: 34027382 DOI: 10.1016/j.mtbio.2021.100111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]